340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Food and Drug Administration issues.
2025 · 2nd Quarter (Apr 1 - June 30)
MERCK & CO., INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- MERCK & CO., INC.
- Filing UUID
- 15adc12c-b503-4c24-ae6c-ca2e14da66b1
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Drug Pricing. S.864 - HELP Copays Act.
Literal federal measure citations: S.864
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.